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Abstract 
Hematoma expansion in intracerebral hemorrhage is associated with poor clinical 
outcome. The ‘spot sign’ is a radiological marker that is associated with hematoma 
expansion, and thought to represent active extravasation of contrast. This case 
demonstrates the use of dynamic CT angiography in identifying the time-dependent 
appearance of a spot sign in a patient with warfarin-associated intracerebral 
hemorrhage. Repeat imaging is also presented which verified cessation of the spot sign 
after INR correction. 
 
Introduction 
Intracerebral hemorrhage (ICH) growth occurs early after onset and has been shown 
to be an independent marker for poor clinical outcome [1–3]. The ‘spot sign’ is thought to 
represent contrast pooling within or around a hematoma and can predict future 
hematoma growth [4]. However, contrary to standard ‘static’ imaging studies that are 
acquired at a particular point in time, dynamic CT angiography (dCTA) demonstrates 
temporal wash-in and wash-out of intravenous contrast material and could capture 
evolution of spot sign in real time [5]. The success of future ICH therapies, including 
hemostatic agents, may depend on accurate determination of hematomas at risk of 
expansion [6, 7]. Here, we present a real-time video (online suppl. video 1, 
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demonstrating spot sign formation from an anticoagulated patient with ICH that resolved 
after INR correction. 
Case Report 
A 63-year-old right-handed female with sudden onset of severe headache and left-sided weakness 
was brought to the emergency department as a ‘stroke code’. She was on long-term anticoagulant 
therapy (warfarin) due to a history of recurrent, unprovoked thromboembolism for 9 years. On 
examination, her blood pressure was 136/60 mm Hg and NIHSS was 8. There was no aphasia or 
dysarthria and visual fields were intact. There was mild left nasolabial flattening but other cranial nerves 
were intact. Motor examination showed left hemiplegia with intact sensation. She was anticoagulated 
with an INR of 3.2. 
Scanning Protocol 
Non-contrast CT head images followed by dCTA acquisition were performed using a 320-row 
volume CT scanner (Aquilion ONE
TM; Toshiba). This system utilizes 320 ultra-high resolution detector 
rows (0.5 mm in width) to image the entire brain in a single gantry rotation. We acquired whole-brain 
images beginning every 2 s over a 1-min sequence, and generated real-time flow videos (online suppl. 
videos 1 and 2) on a Vitrea
TM imaging station for analysis. Hematoma volumes were measured using 
computerized planimetry. The radiation dose for this study was low with a DLP (dose length product) 
reading 1,925 mGy-cm compared to a helical CT head scan having a value of 1,349 mGy-cm. 
Results 
The admission CT scan of the head showed an acute large right medial frontal 
parenchymal hemorrhage measuring approximately 8 × 3 cm in dimension (fig. 1a). The 
hemorrhage was heterogeneous with minimal subarachnoid extension and mild 
perilesional edema. dCTA images demonstrated an increasing area of contrast collection 
seen along the anterior lateral periphery of the hemorrhage consistent with a spot sign 
(fig. 2). This does not appear to be directly connected to a vessel. The spot first appeared 
at 15 s following start of contrast injection, and steadily increased in size during the 
remainder of the acquisition. The maximum density was noted around 25 s; after that, the 
average density decreased with the spot appearing more heterogeneous and the margins 
became ill-defined, consistent with dispersion of contrast in the hematoma. Baseline 
hematoma volume was 56 ml, and peak spot sign density was 480 Hounsfield units. 
Treatment and Follow-Up 
The patient was treated with 2,000 U (factor IX equivalent) of prothrombin complex 
concentrate (PCC), which corrected the INR to 1.5. Repeat imaging at 3 h revealed 
hematoma expansion of 11.2 ml; however, the spot sign was gone on the repeat dCTA 
study (fig. 1e). Absence of contrast extravasation was also confirmed by conventional 
angiogram. The final hematoma volume at 3 days was 52 ml, indicating hematoma 
stabilization and resolution (fig. 1f). 
The patient had no significant change on neurological in-hospital examination, and a 
MRI on day 10 confirmed a large right frontal hematoma which appeared stable in size, Case Rep Neurol 2011;3:154–159 
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with hemorrhage and perilesional edema extending to the right precentral gyrus 
explaining her weakness. There were no other underlying abnormalities seen.  
Her recovery was complicated by a significant proximal left leg DVT, and therefore, an 
IVC filter was placed to prevent pulmonary embolism, and she was started on 
subcutaneous heparin. The patient started to make some gains in her left-sided power by 
the third week, and she was transferred for rehabilitation therapy with 3/5 power in her 
left arm and 1/5 power in her left leg. 
Discussion 
We described the dynamic evolution of a spot sign by dCTA in a patient with warfarin-
associated hemorrhage and its disappearance following INR correction. There was early 
hematoma expansion following the first CTA, as expected given the elevated INR and 
presence of a spot sign. However, after PCC administration and INR correction, the spot 
sign was no longer present, and hematoma volume stabilized.  
The spot sign likely represents contrast extravasation into an ICH and has been 
validated as a predictor for hematoma expansion as well as clinical outcome [4, 6, 8, 9]. 
The CTA spot sign is present in approximately one-third of patients with acute ICH. 
However, its sensitivity is low, most likely as the detection relies on a single snapshot CT 
angiographic acquisition [10, 11]. Extravasation that either begins late, or resolves quickly 
after contrast injection, may be missed with static CTA. Using the new Aquilion ONE 
(Toshiba) volume CT scanner, the dynamic evolution of ‘spot sign’ in an acute 
hemorrhage was described in real time, in what would have otherwise been called a ‘spot-
negative’ patient [5]. This dynamic property has important clinical implications as 
hemostatic therapy is likely of minimal benefit in cases where hematoma expansion is not 
expected [12–14]. 
The pathophysiology behind the spot sign is not known but it has been proposed that 
it may relate to underlying Charcot-Bouchard aneurysms or amyloid-related 
microaneurysms versus active extravasation [4]. The dynamic images clearly show 
contrast extravasation as the cause of ‘spot’ in our patient (fig. 2). dCTA may be useful in 
analyzing the cause(s) of spot sign formation by providing estimations of extravasation 
rate.  
The follow-up dCTA 3 h after treatment with PCC did not reveal a spot sign. It is 
possible that this represents the effect of PCC correction and hematoma stabilization. It is 
also possible that the hematoma may have reached maximal expansion even before PCC 
was instituted. In either case, this result reveals an important tool for use in monitoring 
patients by repeat dCTA to determine if there is ongoing extravasation. 
Conclusion 
This is the first case report we are aware of involving dCTA documentation of a spot 
sign that would be difficult to verify by standard imaging techniques. This case also 
demonstrated hematoma stabilization occurring after INR correction in a warfarin-Case Rep Neurol 2011;3:154–159 
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associated hemorrhage. We propose that future studies incorporating the spot sign also 
examine its dynamic nature. 
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Fig. 1. a Admission non-contrast CT shows a right medial frontal hematoma (volume 56 ml) and a 
small amount of subarachnoid blood in the adjacent posterior frontal sulci. Dynamic CT angiography 
(dCTA) images at 23 s (b) and 31 s (c) show an enlarging spot sign. d Axial images from the admission 
dCTA show a spot sign that disappeared at the 3-hour follow-up dCTA (e) following INR correction 
with PCC. The hematoma volume at 3 h was 67.2 ml. f Follow-up non-contrast CT at 3 days shows that 
the hematoma volume decreased to 52 ml. 
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Fig. 2. This figure illustrates time series of spot sign evolution (time from the start of contrast injection 
is depicted on the lower right hand corner of each image in seconds). Each row shows the spot sign in 
axial (a–f), sagittal (g–l) and coronal (m–r) plane. The spot appeared at 15 s following start of contrast 
injection and steadily increased in size. The maximum density was seen around 31 s; after that, the 
average density reduced and the margins became ill-defined, consistent with dispersion of contrast 
within the hematoma. 
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